相关实验视频
Updated: Jan 14, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.0K
在非小细胞肺癌中TP53功能增益突变的分子特征和治疗影响
Zheng Zhao1, Rui Lu2, Feng Zhang3
1Department of Clinical Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, China.
Cancer medicine
|October 23, 2025
概括
在非小细胞肺癌 (NSCLC) 中TP53功能增益 (GOF) 突变与不同的分子配置和免疫活性有关. 这些突变预测ROS1-TKI治疗的结果较差,但对免疫治疗的反应有所改善.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- TP53功能增益 (GOF) 突变促进癌症进展,并与不良结果相关.
- 了解TP53GOF突变对非小细胞肺癌 (NSCLC) 的特定影响对于治疗分层至关重要.
研究的目的:
- 调查NSCLC中TP53GOF突变的临床和分子关联.
- 评估TP53GOF突变对免疫疗法和ROS1氨酸激酶抑制剂 (TKI) 的治疗反应的影响.
主要方法:
- 来自486名NSCLC患者的DNA测序和临床数据的分析.
- 整合外部NSCLC队列以评估组织学亚型,免疫治疗结果和ROS1-TKI疗效.
- 在TP53GOF和非GOF突变组之间比较分子形状,瘤突变负担和免疫细胞透.
主要成果:
- TP53 GOF突变与明显的分子变异有关,包括增加PIK3CA,STK11和CTNNB1突变,以及更高的瘤突变负担.
- 患有TP53GOF突变的患者显示免疫检查点表达升高,M1巨细胞和CD8+T细胞透,以及B细胞受体信号传递.
- TP53 GOF突变与改善的免疫疗法反应相关,但在NSCLC中ROS1-TKI治疗的结果较差.
结论:
- TP53 GOF突变在NSCLC中定义了一个独特的分子子集,对治疗选择有影响.
- 针对性治疗可能需要考虑TP53突变状态,以获得NSCLC患者的最佳结果.
相关概念视频
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

